• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2291 Share Price Performance

HK$19.63
1.69 (9.42%)
HK$19.63
1.69 (9.42%)
Price HK$19.63

2291 Community Narratives

There are no narratives available yet.

Recent 2291 News & Updates

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Looks Just Right With A 30% Price Jump

Jul 27
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Looks Just Right With A 30% Price Jump

Be Wary Of LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) And Its Returns On Capital

Jul 03
Be Wary Of LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) And Its Returns On Capital

LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Is Increasing Its Dividend To CN¥0.6737

May 25
LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Is Increasing Its Dividend To CN¥0.6737

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 08
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Key Details

CN¥552.2m

Revenue

CN¥70.5m

Cost of Revenue

CN¥481.7m

Gross Profit

CN¥194.4m

Other Expenses

CN¥287.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.83
Gross Margin
87.23%
Net Profit Margin
52.03%
Debt/Equity Ratio
0%

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with high growth potential.

1 Risk
3 Rewards

About 2291

Founded
1994
Employees
374
CEO
Juan Chen
WebsiteView website
www.scientechmed.com

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder products; atrial septal puncture and procedural accessories; interatrial shunt device; mechanical circulatory support products; and hypertensive device treatment products. In addition, it is involved in manufacturing; technology development; and trading activities. The company serves its products through distributors and direct sales. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 0%
  • 3 Months: 17.2%
  • 1 Year: 15.8%
  • Year to Date: 26.2%
The market has been flat over the last week. More promisingly, the market is up 16% over the past year. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›